Quantinuum’s (QNT) Buy Rating Reaffirmed at Rosenblatt Securities

Quantinuum (NASDAQ:QNT – Get Free Report)‘s stock had its “buy” rating reaffirmed by analysts at Rosenblatt Securities in a report released on Thursday, Benzinga reports. They currently have a $155.00 price target on the stock. Rosenblatt Securities’ price objective would indicate a potential upside of 301.03% from the stock’s previous close.

A number of other equities analysts have also recently weighed in on the company. Needham & Company LLC restated a “buy” rating and issued a $100.00 price target on shares of Quantinuum in a report on Wednesday, August 12th. Jefferies Financial Group set a $85.00 price objective on shares of Quantinuum in a research note on Wednesday, August 12th. Bank of America started coverage on shares of Quantinuum in a research note on Monday, June 29th. They set a “buy” rating and a $100.00 price objective on the stock. Evercore started coverage on shares of Quantinuum in a research report on Monday, June 29th. They set an “outperform” rating and a $98.00 target price on the stock. Finally, Zacks Research upgraded shares of Quantinuum to a “hold” rating in a research note on Tuesday, June 30th. Thirteen analysts have rated the stock with a Buy rating, two have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $94.23.

Check Out Our Latest Stock Analysis on Quantinuum

Quantinuum Trading Up 8.3%

Shares of NASDAQ:QNT opened at $38.65 on Thursday. The stock has a 50-day simple moving average of $48.70. Quantinuum has a 12-month low of $33.02 and a 12-month high of $86.79.

Quantinuum (NASDAQ:QNT – Get Free Report) last announced its quarterly earnings results on Tuesday, August 11th. The company reported ($0.28) EPS for the quarter, missing the consensus estimate of ($0.26) by ($0.02). The business had revenue of $8.00 million during the quarter. Sell-side analysts expect that Quantinuum will post -4.76 earnings per share for the current year.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in the stock. SBI Securities Co. Ltd. grew its position in Quantinuum by 52.8% in the 3rd quarter. SBI Securities Co. Ltd. now owns 6,778 shares of the company’s stock worth $326,000 after purchasing an additional 2,343 shares during the last quarter. IFP Advisors Inc raised its holdings in shares of Quantinuum by 1,150.0% during the third quarter. IFP Advisors Inc now owns 1,250 shares of the company’s stock valued at $60,000 after buying an additional 1,150 shares during the last quarter. Counterpoint Mutual Funds LLC bought a new stake in shares of Quantinuum during the third quarter valued at approximately $408,000. Vontobel Holding Ltd. acquired a new position in shares of Quantinuum during the third quarter worth approximately $743,000. Finally, Parisi Gray Wealth Management boosted its position in shares of Quantinuum by 508.7% during the third quarter. Parisi Gray Wealth Management now owns 18,717 shares of the company’s stock worth $900,000 after buying an additional 15,642 shares during the period.

About Quantinuum

(Get Free Report)

Quantinuum is a quantum computing company formed in 2021 through the combination of Honeywell Quantum Solutions and Cambridge Quantum. The company develops full-stack quantum computing technologies designed to support research and commercial applications across industries, including chemistry, materials science, cybersecurity, finance and artificial intelligence.

Its offerings include trapped-ion quantum computers, quantum software and development tools. Quantinuum’s software portfolio includes the TKET quantum compiler, InQuanto quantum chemistry platform, Quantum Origin quantum-enhanced cybersecurity solutions and the Nexus platform for developing and managing quantum applications.

Featured Articles

Analyst Recommendations for Quantinuum (NASDAQ:QNT)

Receive News & Ratings for Quantinuum Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quantinuum and related companies with MarketBeat.com's FREE daily email newsletter.